Will France’s rejection of glyphosate reauthorization block Europe’s proposed re-approval?

Major concerns now hang over the future use of glyphosate in the EU with the move by France not to back its reauthorisation, warned EU Agriculture Commissioner Phil Hogan.

The European Commission has proposed extending approval by 10 years for glyphosate, which is a key active ingredient in Monsanto’s Roundup weedkiller. However, it has stressed that it wants support from member states to renew the licence in the coming months.

“I’m very concerned at the moment, particularly with the recent announcement by France that an essential product like glyphosate which deals with weeds will not be available,” said Mr Hogan as he gave a keynote address at the ASA future of agri-food conference.

“We want member states to come forward and support the science-based recommendation of Commissioner Vytenis Andriukaitis and ensure the continuation of glyphosate for the next 10 years. It is too important for agriculture – and for urban dwellers as well who haven’t access to alternative problems in relation to weeds in their gardens either.”

He pointed out that in general there is “big pressure” to reduce all inputs in agriculture, from fertilizers to all types of chemicals.

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion and analysis. Read full, original post: Hogan ‘very concerned’ after France says no to glyphosate

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT Image May 26, 2026, 08_42_17 AM (1)
Viewpoint: Greenpeace and poison: How environmental advocacy groups rely on compliant (and often ignorant) journalists to spread disinformation and spark litigation
Screenshot 2025-07-30 at 10.48
Can gene editing eliminate Down syndrome? Scientists have done it in lab-grown cells
Screenshot-2026-06-03-at-1.24.46-PM
Challenging anti-GMO disinformation: Why genetically-tweaked crops offer bushels of benefits
ChatGPT-Image-Jun-4-2026-11_49_36-AM-2
‘You don’t understand Tolkien’: Skeptic Pope trolls tech giants about the exaggerated, risk-less benefits of AI
ChatGPT Image May 26, 2026, 08_21_36 AM
Limiting gender affirming interventions: Trump administration targets Texas even though it already bans youth access
Screenshot 2026-05-26 at 10.15
Viewpoint: Double standard—Why does the wellness industry get a free pass while Big Healthcare is treated as morally suspect?
Screenshot-2026-06-04-at-12.05.08-PM
Cases of brain inflammation surge as U.S. measles pandemic approaches 2000
Screenshot-2026-05-28-at-1.36.28-PM
Viewpoint: Can mRNA research survive the Trump administration?
ChatGPT-Image-Jun-4-2026-01_27_58-PM
Viewpoint—N.A.D.+: Why Gwenyth Paltrow’s heralded anti-aging supplement doesn’t work
ChatGPT-Image-Jun-2-2026-03_04_17-PM
Viewpoint: Why the hyper-promoted doping ‘enhanced games’ pseudo Olympics flopped
ChatGPT-Image-May-26-2026-07_51_21-AM-2
Viewpoint: There are more than 1,000 chemicals in a cup of coffee—including many substances that can cause cancer. Why isn’t it banned?
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
ChatGPT-Image-Jun-3-2026-12_33_40-PM-2-1
Viewpoint—The end of ‘ivory tower science’: What does that even mean, and what comes next
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.